Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Fan

Showing results (271-280 of 279) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 279 results.
Emerging Microbes & Infections|April 23, 2021
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamstersBao-Zhong Zhang, Xiaolei Wang, Shuofeng Yuan, et al.
Ebiomedicine|December 15, 2023
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractBingjie Hu, Jasper Fuk-Woo Chan, Yuanchen Liu, et al.
Ebiomedicine|August 14, 2023
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Chest|April 9, 2026
Procedural Techniques, Airway Management and Specimen Acquisition for Peripheral Lung Transbronchial and Endobronchial Ultrasound Guided Cryobiopsy: A Modified Delphi Consensus StatementJason A Beattie, Christopher M Kapp, Jeffrey Thiboutot, et al.
Ebiomedicine|October 24, 2021
Emerging SARS-CoV-2 variants expand species tropism to murinesHuiping Shuai, Jasper Fuk-Woo Chan, Terrence Tsz-Tai Yuen, et al.
Nature Communications|December 11, 2025
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1Jialu Shi, Xiaoyu Zhao, Xiaohui Jin, et al.
Hepatology (Baltimore, Md.)|January 10, 2022
Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCCZhen Wang, Miao Liu, De-Zhi Zhang, et al.
Nature Communications|October 8, 2024
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Gut|July 3, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation studyYan-Jun Xiang, Zong-Han Liu, Jin-Kai Feng, et al.
Pageof 28

Showing results (271-280 of 279) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 279 results.
Emerging Microbes & Infections|April 23, 2021
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamstersBao-Zhong Zhang, Xiaolei Wang, Shuofeng Yuan, et al.
Ebiomedicine|December 15, 2023
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractBingjie Hu, Jasper Fuk-Woo Chan, Yuanchen Liu, et al.
Ebiomedicine|August 14, 2023
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Chest|April 9, 2026
Procedural Techniques, Airway Management and Specimen Acquisition for Peripheral Lung Transbronchial and Endobronchial Ultrasound Guided Cryobiopsy: A Modified Delphi Consensus StatementJason A Beattie, Christopher M Kapp, Jeffrey Thiboutot, et al.
Ebiomedicine|October 24, 2021
Emerging SARS-CoV-2 variants expand species tropism to murinesHuiping Shuai, Jasper Fuk-Woo Chan, Terrence Tsz-Tai Yuen, et al.
Nature Communications|December 11, 2025
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1Jialu Shi, Xiaoyu Zhao, Xiaohui Jin, et al.
Hepatology (Baltimore, Md.)|January 10, 2022
Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCCZhen Wang, Miao Liu, De-Zhi Zhang, et al.
Nature Communications|October 8, 2024
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Gut|July 3, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation studyYan-Jun Xiang, Zong-Han Liu, Jin-Kai Feng, et al.
Pageof 28